Clinical Ethics > Volume 2, Number 1 > Pp. 50-54

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Taylor, J G Search for Related Content Social Bookmarking                      What's this?

Papers

NICE, Alzheimer's and the QALY

J G Taylor

Department of Medicine, University College London; Department General Practice and Primary Care, Kings College London, UK
joseph.taylor{at}ucl.ac.uk

The introduction of National Institute for Health and Clinical Excellence (NICE) guidance on Alzheimer's medication in November 2006 will have a significant effect on the treatment of patients, and is opposed by the Royal College of Psychiatrists and many charities dealing with the elderly. The use of the Quality-Adjusted Life Year (QALY) in the guidance formulation is much debated due to questions of ageism. This article seeks to examine the basis of these accusations and whether NICE can be justified using a utilitarian calculation in a principally egalitarian system such as the NHS.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?